ML20217B866
| ML20217B866 | |
| Person / Time | |
|---|---|
| Issue date: | 08/25/1989 |
| From: | Harold Denton NRC OFFICE OF GOVERNMENTAL & PUBLIC AFFAIRS (GPA) |
| To: | Beckjord E NRC OFFICE OF NUCLEAR REGULATORY RESEARCH (RES) |
| Shared Package | |
| ML20217B758 | List: |
| References | |
| FOIA-98-86, RULE-PRM-35-7 NUDOCS 9804230144 | |
| Download: ML20217B866 (1) | |
Text
_- - -
o o 4*JL,8' ',, UNITED STATES a
$8 NUCLEAR REGULATORY COMMISSION WASHINGTON,0, c. 20555
&;$i? \, /,I y
y a n ,m v
g- _
y b
h A'
MEMORANDUM FOR: Eric S. Beckjord, Director Office of Nuc ear Regulator esearch
+
FROM:
/
paroldR. ,
A recto i 1 Office of vernmental d Public Affairs
SUBJECT:
FINAL CONCURRENCE ON '
{
We have reviewed and concur in the final rulemaking package in response to the petition for rulemaking to add Palladium-103 as a sealed source in seeds to the list of brachytherapy sources in 10 CFR 35.400.
We appreciated the opportunity to work with your staff on this project since its 'veption.
9eo4230144 9eo407 A/a FOIA PDR THOMPSON 98-86 PDR 1
" .' ' ' e, , * ' t,
= -
'y:sly; c.';.
- t. (lQ Cf6, ~ ' ,y^qyy;9::t:y..e c~
g y, ,
@ lY q
/
{. 2. In 5 35.400, paragra;h'(g) is WM to read as follows:
f' -
met sp .w s g,y I 35.400 Use of sources for brachytherapy.
Q$.
- W' Yrij (g) Palladitn-103 as a sealed source in seeds for interstitial treatrent h,h rs" .
of Cancer.
W 4,F F,0 Dated at Ibckv111e, Maryland, this r;
day of -
, 1989.
d.
4'.
r> Ibr the Nuclear Regulatory hinnlan.
1 s
p James M. Taylor, Acting Dce:utive Director for Operations.
t i
e b
C f,C l b CblM
. IPES GPA
+ AD4 IIX) jj RDarnero 10anton <
1ar abrry JTaylor
/ /89
/ /89 f////89 / /89 / /89 g \ .0 RuymA 017:
~
k%:S e
}WE: ATse JI4.lford M is ,ord f IATE: h89 8/l[/89 8/j[/89 8/ /89 8/jf/89 89 8 09
[ Us i OITICIAL RDONO CDFt i
'e I. .
t .,
7
- =